List of insiders holdings for Impax Laboratories LLC:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| HSIAO CHARLES Director | 2007-02-15 21:08:16 | 572,851 3,531,605 | 4,104,456 | Form 5/A |
| HSU LARRY Director | 2015-05-13 20:47:26 | 65,551 2,618,860 | 2,684,411 | Form 4 |
| EDWARDS BARRY R Director | 2007-02-14 21:55:24 | 841,901 0 | 841,901 | Form 5 |
| Wilkinson George Fred Chief Executive Officer | 2016-12-23 14:34:29 | 429,237 0 | 429,237 | Form 4/A |
| CHU MAY Sr. VP Quality Affairs | 2005-03-04 09:56:50 | 231,516 174,027 | 405,543 | Form 4 |
| WOKASCH MICHAEL G Chief Operating Officer | 2004-01-23 10:21:09 | 269,500 0 | 269,500 | Form 5 |
| DOLL DAVID S Exec.VP, Commercial Operations | 2007-02-15 21:10:18 | 147,279 0 | 147,279 | Form 5/A |
| SPIEGLER CORNEL C Chief Financial Officer | 2005-01-18 15:35:33 | 145,750 0 | 145,750 | Form 5 |
| KOCH ARTHUR A JR EVP, Finance, and CFO | 2012-05-30 13:57:47 | 142,415 0 | 142,415 | Form 4 |
| BEN-MAIMON CAROLE President, Global Pharm. | 2014-05-16 14:51:02 | 140,914 0 | 140,914 | Form 4 |
| EDWARDS DAVID J Director | 2005-01-28 14:18:03 | 107,530 0 | 107,530 | Form 5 |
| Hildenbrand Charles V SVP, Operations | 2011-05-31 18:50:12 | 35,222 0 | 35,222 | Form 4 |
| OH KIM SUN Director | 2009-11-12 16:57:45 | 14,000 16,679 | 30,679 | Form 4 |
| Bierly Rick Director | 2017-05-17 15:47:36 | 19,845 0 | 19,845 | Form 4 |
| FLEMING NIGEL Director | 2015-09-01 18:53:14 | 17,200 0 | 17,200 | Form 4 |
| MARKBREITER MICHAEL Director | 2015-09-01 18:30:30 | 12,200 0 | 12,200 | Form 4 |
| TERRERI PETER R Director | 2018-05-08 16:27:44 | 0 0 | 0 | Form 4 |
| Vergis Janet S. Director | 2018-05-08 16:30:08 | 0 0 | 0 | Form 4 |
| PENDERGAST MARY K Director | 2018-05-08 16:25:54 | 0 0 | 0 | Form 4 |
| CHAO ALLEN Director | 2018-05-08 16:24:42 | 0 0 | 0 | Form 4 |
| BUCHI J KEVIN Director | 2018-05-08 16:23:17 | 0 0 | 0 | Form 4 |
| BENET LESLIE Z Director | 2018-05-08 16:20:47 | 0 0 | 0 | Form 4 |
| BURR ROBERT L Director | 2018-05-08 16:19:56 | 0 0 | 0 | Form 4 |
| Nornhold Jeffrey SVP, Technical Operations | 2018-05-08 16:16:57 | 0 0 | 0 | Form 4 |
| SCHLOSSBERG MARK A SVP and General Counsel | 2018-05-08 16:16:10 | 0 0 | 0 | Form 4 |
| NESTOR MICHAEL President, Impax Specialty | 2018-05-08 16:14:45 | 0 0 | 0 | Form 4 |
| Boothe Douglas President, Generics Division | 2018-05-08 16:13:45 | 0 0 | 0 | Form 4 |
| Reasons Bryan M. Chief Financial Officer | 2018-05-08 16:08:54 | 0 0 | 0 | Form 4 |
| BISARO PAUL President and CEO | 2018-05-08 16:06:59 | 0 0 | 0 | Form 4 |
| Mengler Christopher Former Division President | 2010-11-09 09:22:54 | 0 0 | 0 | Form 4 |
| FLEMING US DISCOVERY FUND III LP FLEMING US DISCOVERY OFFSHORE FUND III L P FLEMING US DISCOVERY PARTNERS LP FLEMING US DISCOVERY LLC JPMP CAPITAL CORP J P MORGAN CHASE & CO 10% Owner | 2004-05-27 09:57:18 | 0 0 | 0 | Form 13D |